![Bonnie Feldman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Bonnie Feldman is Vice President-Investor Relations of MediciNova, Inc. She was Vice President of Castle Creek LifeScience Partners LLC.
Dr. Feldman was Healthcare Equity Analyst of Sutro and Company.
She received a BA degree in Economics from the University of California, Los Angeles in 1976, a Doctor of Dental Surgery degree from the University of California, Los Angeles School of Dentistry in 1980 and an MBA degree in Finance from The Anderson School at University of California, Los Angeles in 1996.
Anciens postes connus de Bonnie Feldman
| Sociétés | Poste | Fin |
|---|---|---|
DAFNA Capital Management LLC
 DAFNA Capital Management LLC Investment ManagersFinance DAFNA Capital employs fundamental analysis and event-driven strategies to make long and short investments in publicly traded biotechnology and medical device companies. The firm seeks capital preservation and strong annualized return over longer time periods with minimum risk. Investment returns are generated as a product of recognizing their responsibility to improve human health through the efficient allocation of capital to the most promising preventive, diagnostic, and therapeutic interventions. The majority of their investments are in small/mid-cap companies with a focused pipeline or business and are based in the US or other developed countries. | Analyst-Equity | 31/12/2005 |
| MEDICINOVA, INC. | Public Communications Contact | - |
Formation de Bonnie Feldman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
MediciNova, Inc.
 MediciNova, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which develops novel therapeutics for the treatment of neurological and other disorders | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DAFNA Capital Management LLC
DAFNA Capital Management LLC Investment ManagersFinance DAFNA Capital employs fundamental analysis and event-driven strategies to make long and short investments in publicly traded biotechnology and medical device companies. The firm seeks capital preservation and strong annualized return over longer time periods with minimum risk. Investment returns are generated as a product of recognizing their responsibility to improve human health through the efficient allocation of capital to the most promising preventive, diagnostic, and therapeutic interventions. The majority of their investments are in small/mid-cap companies with a focused pipeline or business and are based in the US or other developed countries. | Finance |
